To Compare the Pharmacokinetics, Safety and Immunogenicity of CT-P55 and Cosentyx in Healthy Subjects

NCT07054970 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Male Subjects

Interventions

BIOLOGICAL: CT-P55
BIOLOGICAL: US-licensed Cosentyx
BIOLOGICAL: EU-approved Cosentyx

Sponsor

Celltrion